News

PharmaJet, the maker of innovative, needle-free injection technology, announced that its Tropis Needle-free injection system will be used to deliver a COVID-19 vaccine being developed…
Read More...

AstraZeneca will initiate a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response (cytokine storm)…
Read More...

Sanofi and GSK announce that they have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19, using innovative technology from both…
Read More...

Immunotherapy companies led by Dr. Patrick Soon-Shiong are developing potential coronavirus therapeutics and vaccines to address the evolving stages of disease from moderate infection…
Read More...

Insilico Medicine announced that it has entered into a research collaboration with Boehringer Ingelheim to utilize Insilico's generative machine learning technology and proprietary…
Read More...

Ascletis Pharma Inc. announces that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F…
Read More...

Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for an orally available…
Read More...

Hope Biosciences announced that FDA has approved a Phase II clinical trial evaluating the safety and efficacy of Hope Biosciences’ allogeneic, adipose-derived mesenchymal stem cells…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced that the US Food and Drug Administration (FDA) has approved the…
Read More...

Celltrion announced that the company has successfully selected the most potent antibody candidates to neutralize SARS-CoV-2, the virus causing COVID-19. Through a partnership with…
Read More...

Blackstone and Alnylam Pharmaceuticals, Inc. announced the companies have entered into a broad strategic collaboration under which Blackstone will provide up to $2 billion to support…
Read More...

The U.S. Food and Drug Administration approved Koselugo (selumetinib) for the treatment of pediatric patients, 2 years of age and older, with neurofibromatosis type 1 (NF1), a genetic…
Read More...

BioNTech SE and Pfizer Inc. today disclosed additional details of their collaboration to advance candidates from BioNTech’s mRNA vaccine program, previously announced on March 17, 2020.…
Read More...

NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced it has entered into a clinical collaboration agreement with Bristol Myers Squibb to evaluate…
Read More...

Recipharm announced that Erdosteine will be tested in a clinical study as an add-on treatment for COVID-19 patients. The clinical study, which began on 7th April, is being conducted…
Read More...

Regeneron Pharmaceuticals, Inc. and Zai Lab Limited announced a strategic collaboration for the development and commercialization of REGN1979 (CD20xCD3 bispecific antibody) in mainland…
Read More...

Avacta Group plc announced that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. The companies will develop and manufacture an…
Read More...

Acceleron Pharma Inc. announced that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sotatercept for the treatment of patients with…
Read More...

Global biotherapeutics leader, CSL Behring and innovative human antibody development company SAB Biotherapeutics (SAB) announced their partnership to combat the coronavirus pandemic…
Read More...

OncoImmune, Inc. has received a study-may-proceed letter from the FDA for its Phase III clinical trial testing the safety and efficacy of CD24Fc for the treatment of hospitalized…
Read More...